Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02448810
Title Phase 2a Study of BAX69 and 5-FU/Leucovorin or Panitumumab Versus Standard of Care in Subjects With Metastatic Colorectal Cancer
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Baxalta US Inc.
Indications

colorectal cancer

Therapies

Fluorouracil + Leucovorin

Imalumab

Panitumumab

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Hematology Oncology Associates of the Treasure Coast Port Saint Lucie Florida 34952 United States Details
Joliet Oncology-Hematology Associates, Ltd. Joliet Illinois 60435 United States Details
Indiana University Health Goshen Indiana 46526 United States Details
Maryland Oncology Hematology, P.A. Rockville Maryland 20850 United States Details
Washington University School of Medicine Saint Louis Missouri 63110 United States Details
Montefiore Einstein Center for Cancer Care Bronx New York 10461 United States Details
Mount Sinai Beth Israel New York New York 10003 United States Details
University of Oklahoma Health Sciences Center Oklahoma City Oklahoma 73104 United States Details
Medical University of South Carolina (MUSC) Charleston South Carolina 29412 United States Details
The Jones Clinic, PC Germantown Tennessee 38138 United States Details
Mary Crowley Cancer Research Center Dallas Texas 75230 United States Details
CTRC at University of Texas Health Science Center San Antonio Texas 78229 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field